UNSPSC 51101920: Artemisinin

This classification denotes an antiprotozoal agent with the molecular formula C15H22O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9RMU91N5K2, chemically known as 3,12-epoxy-12h-pyranol(4,3-j)-1,2-benzodioxepin-10(3h)-one, octahydro-3,6,9-trimethyl-, (3-alpha,5a-beta,6-beta,8a-beta,9-alpha,12-beta,12ar*)-(+)- but generally known as artemisinin, which bears US NIH Compound Identifier 68827. artemisinin most often comes in base, type a, and type b forms.

UNSPSC 51101920 Artemisinin, a Commodity code, shows minimal recent state and local procurement activity directly aligned with the code's nominal scope. The two recent opportunities tagged to this code involve pharmaceutical procurement, but neither actually solicits artemisinin: the Illinois Department of Public Health awarded a piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets (an awarded contract, not an open solicitation); Seminole County, Florida issued an IFB for Naloxone and Safe Drug Deactivation Systems for community health initiatives. The mismatch between the code and the actual purchases suggests the recent opportunities are miscoded or the code does not see regular state and local procurement activity.

Geographic activity is concentrated in Florida and Illinois based on recent records, though the sample size is too small to establish a meaningful pattern. The Illinois Department of Public Health contract awarded $2,999,999.11 over a three-year term (12 months initial plus two renewal options), while Seminole County's procurement was structured for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries and a two-year initial term plus one-year renewal option. Neither opportunity included explicit set-aside designations for small business, minority-owned, women-owned, or veteran-owned enterprises. Business development professionals should verify whether this code aligns with their product or service offering before pursuing opportunities tagged to it, given the apparent disconnect between the nominal scope and recent activity.